SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-08-009170
Filing Date
2008-08-08
Accepted
2008-08-08 16:30:38
Documents
6
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y65184e10vq.htm 10-Q 232315
2 EX-3.6: AMENDED AND RESTATED BY-LAWS y65184exv3w6.htm EX-3.6 90014
3 EX-31.1: CERTIFICATION y65184exv31w1.htm EX-31.1 9023
4 EX-31.2: CERTIFICATION y65184exv31w2.htm EX-31.2 9011
5 EX-32.1: CERTIFICATION y65184exv32w1.htm EX-32.1 3152
6 EX-32.2: CERTIFICATION y65184exv32w2.htm EX-32.2 3335
  Complete submission text file 0000950123-08-009170.txt   348508
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 081002915
SIC: 2836 Biological Products, (No Diagnostic Substances)